Leukocyte adhesion deficiencies: Molecular basis, clinical findings, and therapeutic options

Advances in Experimental Medicine and Biology

Volumn 601, Issue , 2007, Pages 51-60

  Etzioni, Amos ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; LIGAND;

BIOLOGICAL MODEL; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHESION DEFICIENCY; METABOLISM; PHENOTYPE; REVIEW; SYNDROME; VASCULAR ENDOTHELIUM;

ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTEGRINS; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; LEUKOCYTES; LIGANDS; MODELS, BIOLOGICAL; PHENOTYPE; SYNDROME;

EID: 34848859336     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-72005-0_5     Document Type: Conference Paper

References (36)

1. Alon, R., Aker, M., Feigelson, S., Sokolovsky-Eisenberg, M., Staunton, D.E., Cinamon, G., Grabovsky, V., Shamri, R. and Etzioni, A. (2003) A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood 101, 4437-4445.
2. Alon, R. and Etzioni, A. (2003) LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 24, 561-566.
3. Anderson, D.C. and Smith, C.W. (2001). Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility. New York, McGraw-Hill.
4. Bauer, T.R., Jr., Hai, M., Tuschong, L.M., Burkholder, T.H., Gu, Y.C., Sokolic, R.A., Ferguson, C., Dunbar, C.E. and Hickstein, D.D. (2006) Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy. Blood 108, 3313-3320.
5. Bauer, T.R., Jr. and Hickstein, D.D. (2000) Gene therapy for leukocyte adhesion deficiency. Curr. Opin. Mol. Ther. 2, 383-388.
6. Bos, J.L., De Rooij, J. and Reedquist, K.A. (2001) Rap1 signalling: Adhering to new models. Nat. Rev. Mol. Cell. Biol. 2, 369-377.
7. Crittenden, J.R., Bergmeier, W., Zhang, Y., Piffath, C.L., Liang, Y., Wagner, D.D., Housman, D.E. and Graybiel, A.M. (2004) CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat. Med. 10, 982-986.
8. Etzioni, A. (1996) Adhesion molecules- role in health and disease. Pediat. Res. 39, 191-198.
9. Etzioni, A., Frydman, M., Pollack, S., Avidor, I., Phillips, M.L., Paulson, J.C. and Gershoni- Baruch, R. (1992) Brief report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. 327, 1789-1792.
10. Etzioni, A., Gershoni-Baruch, R., Pollack, S. and Shehadeh, N. (1998) Leukocyte adhesion deficiency type II: Long-term follow-up. J. Allergy Clin. Immunol. 102, 323-324.
11. Etzioni, A. and Tonetti, M. (2000) Fucose supplementation in leukocyte adhesion deficiency type II. Blood 95, 3641-3643.
12. Fischer, A., Lisowska-Grospierre, B., Anderson, D. and Springer, T. (1988) Leukocyte adhesion deficiency: Molecular basis and functional consequences. Immunol. Rev. 1, 39-54.
13. Harris, E.S., Shigeoka, A.O., Li, W., Adams, R.H., Prescott, S.M., McIntyre, T.M., Zimmerman, G.A. and Lorant, D.E. (2001) A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by β1 and β2 integrins. Blood 97, 767-776.
14. Helmus, Y., Denecke, J., Yakubenia, S., Robinson, P., Luhn, K., Watson, D.L., McGrogan, P.J., Vestweber, D., Marquardt, T. and Wild, M.K. (2006) Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood 107, 3959-3966.
15. Hogg, N., Stewart, M.P., Scarth, S.L., Newton, R., Shaw, J.M., Law, S.K. and Klein, N. (1999) A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J. Clin. Invest. 103, 97-106.
16. Karsan, A., Cornejo, C.J., Winn, R.K., Schwartz, B.R., Way, W., Lannir, N., Gershoni- Baruch, R., Etzioni, A., Ochs, H.D. and Harlan, J.M. (1998) Leukocyte adhesion deficiency type II is a generalized defect of De novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium. J. Clin. Invest. 101, 2438-2445.
17. Kinashi, T. (2005) Intracellular signalling controlling integrin activation in lymphocytes. Nat. Rev. Immunol. 5, 546-559.
18. Kinashi, T., Aker, M., Sokolovsky-Eisenberg, M., Grabovsky, V., Tanaka, C., Shamri, R., Feigelson, S., Etzioni, A. and Alon, R. (2004) LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood 103, 1033-1036.
19. Kuijpers, T.W., Van Lier, R.A., Hamann, D., De Boer, M., Thung, L.Y., Weening, R.S., Verhoeven, A.J. and Roos, D. (1997) Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J. Clin. Invest. 100, 1725-1733.
20. Lorusso, F., Kong, D., Jalil, A.K., Sylvestre, C., Tan, S.L. and Ao, A. (2006) Preimplantation genetic diagnosis of leukocyte adhesion deficiency type I. Fertil. Steril. 85, 494 e415-e498.
21. Lubke, T., Marquardt, T., Etzioni, A., Hartmann, E., von Figura, K. and Korner, C. (2001) Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28, 73-76.
22. Lubke, T., Marquardt, T., von Figura, K. and Korner, C. (1999) A new type of carbohydratedeficient glycoprotein syndrome due to a decreased import of GDP-fucose into the golgi. J. Biol. Chem. 274, 25986-25989.
23. Luo, Y. and Haltiwanger, R.S. (2005) O-fucosylation of notch occurs in the endoplasmic reticulum. J. Biol. Chem. 280, 11289-11294.
24. Luster, A.D., Alon, R. and von Andrian, U.H. (2005) Immune cell migration in inflammation: Present and future therapeutic targets. Nat. Immunol. 6, 1182-1190.
25. Marquardt, T., Luhn, K., Srikrishna, G., Freeze, H., Harms, E. and Vestweber, D. (1999) Correction of LAD type II with oral fucose. Blood 94, 3976-3985.
26. McDowall, A., Inwald, D., Leitinger, B., Jones, A., Liesner, R., Klein, N. and Hogg, N. (2003) A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins. J Clin. Invest. 111, 51-60.
27. Roos, D., Meischl, C., De Boer, M., Simsek, S., Weening, R.S., Sanal, O., Tezcan, I., Gungor, T. and Law, S.K. (2002) Genetic analysis of patients with leukocyte adhesion deficiency: Genomic sequencing reveals otherwise undetectable mutations. Exp. Hemat. 30, 252-261.
28. Shamri, R., Grabovsky, V., Gauguet, J.M., Feigelson, S., Manevich, E., Kolanus, W., Robinson, M.K., Staunton, D.E., von Andrian, U.H. and Alon, R. (2005) Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat. Immunol. 6, 497-506.
29. Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76, 301-314.
30. Sturla, L., Rampal, R., Haltiwanger, R.S., Fruscione, F., Etzioni, A. and Tonetti, M. (2003) Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in leukocyte adhesion deficiency type II (CDG IIc). J. Biol. Chem. 278, 26727-26733.
31. Thomas, C., Le Deist, F., Cavazzana-Calvo, M., Benkerrou, M., Haddad, E., Blanche, S., Hartmann, W., Friedrich, W. and Fischer, A. (1995) Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 86, 1629-1635.
32. Tone, Y., Wada, T., Shibata, F., Toma, T., Hashida, Y., Kasahara, Y., Koizumi, S. and Yachie, A. (2007) Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood 109, 1182-1184.
33. von Andrian, U.H., Berger, E.M., Ramezani, L., Chambers, J.D., Ochs, H.D., Harlan, J.M., Paulson, J.C., Etzioni, A. and Arfors, K.E. (1993) In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J. Clin. Invest. 91, 2893-2897.
34. von Andrian, U.H. and Mackay, C.R. (2000) T cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343, 1020-1034.
35. Wild, M.K., Luhn, K., Marquardt, T. and Vestweber, D. (2002) Leukocyte adhesion deficiency II: Therapy and genetic defect. Cells Tissues Organs 172, 161-173.
36. Yakubenia, S. and Wild, M.K. (2006) Leukocyte adhesion deficiency II. Advances and open questions. FEBS J. 273, 4390-4398.